Rathbones Group’s Clover Health Investments CLOV Stock Holding History

Rathbones Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.5K	Hold	23,000	–	–	﹤0.01%	637
2025 Q4	$54K	Hold	23,000	–	–	﹤0.01%	620
2025 Q3	$70.4K	Hold	23,000	–	–	﹤0.01%	618
2025 Q2	$64.2K	Hold	23,000	–	–	﹤0.01%	599
2025 Q1	$82.6K	Hold	23,000	–	–	﹤0.01%	566
2024 Q4	$72.5K	Hold	23,000	–	–	﹤0.01%	578
2024 Q3	$64.9K	Sell	23,000 -2,000	-8%	-$4.58K	﹤0.01%	576
2024 Q2	$30.8K	Hold	25,000	–	–	﹤0.01%	603
2024 Q1	$19.9K	Hold	25,000	–	–	﹤0.01%	606
2023 Q4	$23.8K	Sell	25,000 -63	-0.3%	-$62	﹤0.01%	603
2023 Q3	$27.1K	Buy	+25,063	New	+$29.8K	﹤0.01%	613

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rathbones Group's CLOV Position: Q1 2026 in Review

Rathbones Group held its Clover Health Investments (CLOV) position steady in Q1 2026 at 23,000 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Rathbones Group first reported a position in CLOV in Q3 2023 and has held it in 11 quarters since. The position peaked at $82.6K in Q1 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Rathbones Group held 23,000 shares of Clover Health Investments worth $40.5K as of Q1 2026.
Rathbones Group left its Clover Health Investments share count unchanged in Q1 2026.
Clover Health Investments made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #637 holding.
Rathbones Group first reported a position in Clover Health Investments in Q3 2023 and has held it in 11 quarters since.
Rathbones Group's Clover Health Investments position peaked at $82.6K in Q1 2025.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.